Jazz Pharmaceuticals (JAZZ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Jazz Pharmaceuticals | JAZZ | Healthcare | Biotechnology | 77 | 21.6% |
| Current Price (09/17) | $133.22 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 2,625.8 | |||
| Sales Growth Forecast | 15.3% | |||
| Net Profit Margin | 36.0% | |||
| Projected Shares Outstanding | 59.75 | |||
| EPS - Five year Forecast | $32.24 | |||
| Average P/E Ratio | 11.0 | |||
| Projected Average Price | $354.66 | |||
| Price Appreciation (Annualized) | 21.6% | |||
| Annual Dividend Yield | 0.0% | |||
| Projected Annual Return | 21.6% | |||
| Quality | ||||
| Financial Strength | 76 | 19.0 | ||
| EPS Stability | 67 | 16.7 | ||
| Industry Sales Growth Rate | 15.0% | 12.8 | ||
| Industry Net Profit Margin | 30.0% | 15.0 | ||
| Calculated Quality Rating | 63.4 | |||
| Fool CAPS | ||||
Total Players
281
Outperforms
66
Underperforms
All-Stars (69)
54
Outperforms (78%)
15
Underperforms
|
||||
| Fundamental Data Updated: 08/06/2021 | ||||